ArticleEuropean urology open science2026
Real-world Impact of Integrating Comprehensive Geriatric Assessment into Clinical Treatment Decision-making for Older Patients with Bladder Cancer.
Article in European urology open science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Frailty: from concept to clinical practice in urology.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective: Treatment decision-making in older patients with bladder cancer (BC) is complicated by frailty and comorbidities. Comprehensive geriatric assessment (CGA) may support this process. This study evaluated the impact of CGA on treatment selection and identified CGA-prompted interventions in older patients with high-risk non-muscle-invasive BC (NMIBC) or muscle-invasive BC (MIBC). Design setting participants and intervention: Patients aged ≥70 yr or aged <70 yr and deemed frail were referred for CGA after multidisciplinary team (MDT) discussion. Outcomes were discussed at a subsequent MDT meeting, and changes in treatment plans were recorded. The impact of CGA was defined as (1) modification of proposed treatment, (2) assessment of functional status because of concerns about resilience for treatment, or (3) guidance among multiple treatment options. Medical records were examined for CGA-prompted interventions. Overall survival (OS) was described according to CGA impact. Results and limitations: Among 201 patients (79% male, median age 76 yr), CGA influenced treatment selection in 19% ( Conclusions: CGA contributed to treatment selection in 1 in 5 patients, leading to de-escalation in frailer patients and supporting decisions when resilience or treatment choice was uncertain, demonstrating its potential to optimise treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.